In response to TS treatment, tumor cell proliferation was shown to be suppressed by arresting colon cancer HCT116 cells in the G1 and G2/M phase population through decreasing cyclin D1 expression and upregulating p21 and the tumor suppressor gene p53. This evidence concerns the gene TP53 and neoplasm.